Gender-affirming hormone therapy will be offered under the universal healthcare scheme starting this week, deputy government spokeswoman Ploythalay Laksameesaengjan says.
The announcement comes during Pride Month, as Thailand continues efforts to expand healthcare access and legal recognition for LGBTQ+ communities.
Ms Ploythalay said the programme is intended to help transgender people access hormone treatment safely within the healthcare system.
The National Health Security Office has completed procurement of hormone therapy medications, with distribution expected to begin on Wednesday through 50 participating healthcare facilities nationwide, she said.
The programme covers eight hormone-related medicines divided into four categories: female hormones in oral and topical forms, injectable male hormones, oral androgen blockers and central hormone-suppressing injections.
Also available are health screenings, mental health counselling and laboratory tests for hormone levels, liver and kidney function, and metabolic health.
Ms Ploythalay said hormone therapy can have physical and psychological side effects if not properly managed.
Those seeking therapy are advised to undergo counselling beforehand and remain under the supervision of qualified professionals throughout.